Grifols, S.A. (GRFS) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $5.06B, a trailing price-to-earnings ratio of 9.9 and a free-cash-flow yield of 14.1%. Over the most recent reported fiscal year, revenue grew 4.3% and free cash flow per share grew 17.4%.